For the study, researchers tracked 1,070 kids aged 12 to 18 who were overweight or obese and also had a diagnosis of asthma.

Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...

Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Paediatricians are observing a concerning rise in early-onset asthma among children, particularly in cities with poor air ...

Marketed as Exdensur, the ultra-long-acting biologic is the first of its kind, requiring only two injections per year to ...

Medically reviewed by Daniel More, MD Key Takeaways Asthma action plans help maintain good asthma control by outlining ...

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday, the U.S. regulator greenlit GSK’s depemokimab, an ultra-long-acting ...

The study is part of a growing body of research examining the benefits of climate change solutions on human health.

The parents of a 13-year-old girl who died after an asthma attack led to a cardiac arrest have said they fear "other families will lose children because asthma is too easily dismissed".